Revelation Biosciences Stock Market Value
| REVB Stock | USD 0.76 0.01 1.33% |
| Symbol | Revelation |
Revelation Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revelation Biosciences. If investors know Revelation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revelation Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (17.53) | Return On Assets (0.51) | Return On Equity (2.70) |
The market value of Revelation Biosciences is measured differently than its book value, which is the value of Revelation that is recorded on the company's balance sheet. Investors also form their own opinion of Revelation Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Revelation Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revelation Biosciences' market value can be influenced by many factors that don't directly affect Revelation Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revelation Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revelation Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revelation Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Revelation Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Revelation Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Revelation Biosciences.
| 06/03/2024 |
| 11/30/2024 |
If you would invest 0.00 in Revelation Biosciences on June 3, 2024 and sell it all today you would earn a total of 0.00 from holding Revelation Biosciences or generate 0.0% return on investment in Revelation Biosciences over 180 days. Revelation Biosciences is related to or competes with Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, Enliven Therapeutics, and Molecular Partners. Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercializati... More
Revelation Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Revelation Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Revelation Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 34.52 | |||
| Value At Risk | (7.83) | |||
| Potential Upside | 8.97 |
Revelation Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Revelation Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Revelation Biosciences' standard deviation. In reality, there are many statistical measures that can use Revelation Biosciences historical prices to predict the future Revelation Biosciences' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (1.45) | |||
| Treynor Ratio | 0.9299 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Revelation Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Revelation Biosciences Backtested Returns
Revelation Biosciences maintains Sharpe Ratio (i.e., Efficiency) of -0.0728, which implies the firm had a -0.0728% return per unit of risk over the last 3 months. Revelation Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Revelation Biosciences' Variance of 32.95, risk adjusted performance of (0.06), and Coefficient Of Variation of (1,186) to confirm the risk estimate we provide. The company holds a Beta of -0.53, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Revelation Biosciences are expected to decrease at a much lower rate. During the bear market, Revelation Biosciences is likely to outperform the market. At this point, Revelation Biosciences has a negative expected return of -0.39%. Please make sure to check Revelation Biosciences' potential upside, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Revelation Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.09 |
Virtually no predictability
Revelation Biosciences has virtually no predictability. Overlapping area represents the amount of predictability between Revelation Biosciences time series from 3rd of June 2024 to 1st of September 2024 and 1st of September 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Revelation Biosciences price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Revelation Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | 0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Revelation Biosciences lagged returns against current returns
Autocorrelation, which is Revelation Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Revelation Biosciences' stock expected returns. We can calculate the autocorrelation of Revelation Biosciences returns to help us make a trade decision. For example, suppose you find that Revelation Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Revelation Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Revelation Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Revelation Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Revelation Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Revelation Biosciences Lagged Returns
When evaluating Revelation Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Revelation Biosciences stock have on its future price. Revelation Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Revelation Biosciences autocorrelation shows the relationship between Revelation Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Revelation Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Revelation Biosciences is a strong investment it is important to analyze Revelation Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Revelation Biosciences' future performance. For an informed investment choice regarding Revelation Stock, refer to the following important reports:Check out Revelation Biosciences Correlation, Revelation Biosciences Volatility and Revelation Biosciences Alpha and Beta module to complement your research on Revelation Biosciences. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Revelation Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.